Stockscreener 앱 받기
81.44
0.27%
-0.22
시간 외 거래:
80.01
-1.43
-1.76%
전일 마감가:
$81.66
열려 있는:
$80.25
하루 거래량:
455.97K
Relative Volume:
1.57
시가총액:
$1.18B
수익:
$1.80M
순이익/손실:
$1.76B
주가수익비율:
0.6862
EPS:
118.674
순현금흐름:
$-149.23M
1주 성능:
+38.39%
1개월 성능:
+128.44%
6개월 성능:
+570.29%
1년 성능:
+415.44%
1일 변동 폭
$77.58
$82.48
1주일 범위
$57.83
$83.95
52주 변동 폭
$10.80
$83.95
인히브릭스 Stock (INBX) Company Profile
명칭
Inhibrx Biosciences Inc
전화
(858) 795-4220
주소
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
INBX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
81.44 | 1.18B | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
인히브릭스 Stock (INBX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | JMP Securities | Mkt Perform |
| 2024-01-23 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 개시 | SMBC Nikko | Outperform |
| 2021-09-21 | 개시 | JMP Securities | Mkt Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-09-14 | 개시 | Credit Suisse | Outperform |
| 2020-09-14 | 개시 | Evercore ISI | Outperform |
모두보기
인히브릭스 주식(INBX)의 최신 뉴스
Is Inhibrx Biosciences Inc. stock a buy in volatile marketsIndex Update & AI Enhanced Trading Alerts - newser.com
Is Inhibrx Biosciences Inc. stock resilient to inflationJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
How high can Inhibrx Biosciences Inc. stock go2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com
Published on: 2025-11-03 05:26:29 - newser.com
Why Inhibrx Biosciences Inc. stock appeals to analystsFed Meeting & Daily Market Momentum Tracking - newser.com
Tick level data insight on Inhibrx Biosciences Inc. volatilityJuly 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
Regression analysis insights on Inhibrx Biosciences Inc. performanceQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
What Wall Street predicts for Inhibrx Biosciences Inc. stock price2025 Big Picture & Technical Buy Zone Confirmations - newser.com
Inhibrx Biosciences Inc. stock daily chart insightsJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Will Inhibrx Biosciences Inc. stock benefit from sector rotation2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
Ethic Inc. Purchases New Shares in Inhibrx Biosciences, Inc. $INBX - MarketBeat
Inhibrx Biosciences stock hits all-time high of 83.93 USD By Investing.com - Investing.com Australia
Inhibrx Biosciences stock hits all-time high of 83.93 USD - Investing.com
What does recent volatility data suggest for Inhibrx Biosciences Inc.Quarterly Risk Review & AI Optimized Trading Strategy Guides - newser.com
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
How to recover losses in Inhibrx Biosciences Inc. stock2025 Short Interest & Community Verified Trade Signals - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Trading Up 7.8%What's Next? - MarketBeat
Published on: 2025-10-30 05:00:27 - newser.com
Published on: 2025-10-30 02:27:04 - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Inhibrx Biosciences (NASDAQ:INBX) Hits New 12-Month HighHere's What Happened - MarketBeat
How hedge fund analytics apply to Inhibrx Biosciences Inc. stockTrade Volume Summary & Low Drawdown Momentum Ideas - newser.com
Published on: 2025-10-28 03:10:26 - newser.com
How Inhibrx Biosciences Inc. stock valuations compare to rivalsMarket Movement Recap & Daily Entry Point Trade Alerts - Fundação Cultural do Pará
Is Inhibrx Biosciences Inc. stock supported by innovation pipelineJuly 2025 Selloffs & Entry Point Confirmation Signals - fcp.pa.gov.br
Is Inhibrx Biosciences Inc. stock recession proof2025 Trade Ideas & Free Community Consensus Stock Picks - Fundação Cultural do Pará
Inhibrx Biosciences: Cruising Toward FDA Approval, But Getting Ahead Of Itself - Seeking Alpha
인히브릭스 (INBX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):